Company News-Beijing Cygenta Biotech Co., Ltd.



2024-12-19 What are the difficulties in the iPSC cell bank?

Find out more
2024-12-16 Wang Yuzhu, deputy director of the Science Park Management Committee of Xiongan New District, and his entourage visited Cygenta research.

Find out more
2024-12-12 Good news! Cygent postdoctoral research station was officially approved, opening a new chapter of deep integration of production, research and research

Find out more
2024-12-05 The final guarantee for the preparation of gene therapy products-aseptic filling

Find out more
2024-11-15 Zhang Bo, member of the Standing Committee of Beijing Daxing District Committee and Secretary of the Political and Legal Committee, visited Cygent to investigate

Find out more
2024-11-14 "One-stop" & "dual-system" AAV platform solution accelerates the commercialization of gene therapy products

Find out more
2024-11-05 Meeting Forecast | Ms. Zhang Shixian, Vice President of Cygenta Health Technology, was invited to participate in the new generation of CGT drug technology exchange and sharing meeting of

Find out more
2024-10-30 Cygenta warmly congratulates the West Lake University/West Lake Laboratory for the treatment of advanced glioblastoma innovative CAR-T cell product WL276 to start clinical trials!

Find out more
2024-10-23 Cygenta zero defect through the National Health Commission on-site verification

Find out more
2024-10-14 Cygenta Health Helps Imunopharm Approved the First Clinical Trial of Colorectal Cancer CAR-T in China

Find out more
2024-06-29 Sailing out to sea | 2024 The 2nd China Medicine Valley Cell and Gene Therapy Industry Development Forum was successfully held

Find out more
2024-02-13 Plasmids: A Key Role in the New Era of Biotechnology

Find out more

<
1
2
3
>